Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials.
- DOI
- 10.1093/ofid/ofag265
- Published
- 2026 May
- Container
- Open forum infectious diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ofid/ofag265,
title = {Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials.},
author = {Post FA and Wohl D and Liegeon G and Brar I and Hagins D and Yazdanpanah Y and Avihingsanon A and Liu H and Aizen K and Hindman JT and Gupta S},
year = {2026},
journal = {Open forum infectious diseases},
doi = {10.1093/ofid/ofag265},
url = {https://doi.org/10.1093/ofid/ofag265}
}RIS
TY - JOUR TI - Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials. AU - Post FA AU - Wohl D AU - Liegeon G AU - Brar I AU - Hagins D AU - Yazdanpanah Y AU - Avihingsanon A AU - Liu H AU - Aizen K AU - Hindman JT AU - Gupta S PY - 2026 JO - Open forum infectious diseases DO - 10.1093/ofid/ofag265 UR - https://doi.org/10.1093/ofid/ofag265 ER -
APA
FA, P., D, W., G, L., I, B., D, H., Y, Y., A, A., H, L., K, A., JT, H., & S, G. (2026). Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofag265
Source records
- pubmed · retrieved 2026-09-27T07:43:53.672Z